Growth Metrics

Marimed (MRMD) Receivables - Net (2016 - 2025)

Marimed has reported Receivables - Net over the past 14 years, most recently at $9.1 million for Q4 2025.

  • Quarterly Receivables - Net rose 4.26% to $9.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $9.1 million through Dec 2025, up 4.26% year-over-year, with the annual reading at $9.1 million for FY2025, 4.26% up from the prior year.
  • Receivables - Net was $9.1 million for Q4 2025 at Marimed, up from $8.0 million in the prior quarter.
  • Over five years, Receivables - Net peaked at $9.2 million in Q1 2025 and troughed at $1.7 million in Q4 2021.
  • The 5-year median for Receivables - Net is $7.3 million (2021), against an average of $6.9 million.
  • Year-over-year, Receivables - Net crashed 75.04% in 2021 and then soared 425.81% in 2022.
  • A 5-year view of Receivables - Net shows it stood at $1.7 million in 2021, then soared by 425.81% to $8.8 million in 2022, then fell by 17.82% to $7.2 million in 2023, then grew by 21.43% to $8.7 million in 2024, then increased by 4.26% to $9.1 million in 2025.
  • Per Business Quant, the three most recent readings for MRMD's Receivables - Net are $9.1 million (Q4 2025), $8.0 million (Q3 2025), and $7.7 million (Q2 2025).